Yuto Yasuda

573 total citations
35 papers, 346 citations indexed

About

Yuto Yasuda is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yuto Yasuda has authored 35 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Yuto Yasuda's work include Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (5 papers). Yuto Yasuda is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (5 papers). Yuto Yasuda collaborates with scholars based in Japan, Canada and United States. Yuto Yasuda's co-authors include Hironori Yoshida, Hiroaki Ozasa, Takashi Nomizo, Takahiro Tsuji, Yuichi Sakamori, Tomoko Funazo, Toyohiro Hirai, Young Hak Kim, Hiroki Nagai and Yasushi Yoshimura and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Yuto Yasuda

34 papers receiving 344 citations

Peers

Countries citing papers authored by Yuto Yasuda

Since Specialization

Citations

This map shows the geographic impact of Yuto Yasuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuto Yasuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuto Yasuda more than expected).

Fields of papers citing papers by Yuto Yasuda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuto Yasuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuto Yasuda. The network helps show where Yuto Yasuda may publish in the future.

Co-authorship network of co-authors of Yuto Yasuda

This figure shows the co-authorship network connecting the top 25 collaborators of Yuto Yasuda. A scholar is included among the top collaborators of Yuto Yasuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuto Yasuda. Yuto Yasuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Characteristics of lung resistance and elastance associated with tracheal stenosis and intrapulmonary airway narrowing in ex vivo sheep lungs	Respiratory Research	Yuto Yasuda, Geoffrey N. Maksym et al.	1
2	Rho-Kinase Inhibition of Active Force and Passive Tension in Airway Smooth Muscle: A Strategy for Treating Airway Hyperresponsiveness in Asthma	Biology	Yuto Yasuda, Lu Wang et al.	3
3	Critical roles of airway smooth muscle in mediating deep-inspiration-induced bronchodilation: a big stretch?	Respiratory Research	Yuto Yasuda, Lu Wang et al.	1
4	Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19: A retrospective study	Respiratory Medicine and Research	Yuto Yasuda, Yutaka Hirayama et al.	4
5	The safety and efficacy of durvalumab consolidation therapy in the management of patients with stage III non-small-cell lung cancer and preexisting interstitial lung disease	Respiratory Investigation	Yuto Yasuda, Junko Tanizaki et al.	6
6	Aluminium Gauze Reduces SARS-CoV-2 Viral Load in Non-Woven Masks Worn by Patients with COVID-19	Infectious Disease Reports	Yuto Yasuda, Kazuo Murai et al.	2
7	Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance Model	Molecular Cancer Therapeutics	Tomoko Funazo, Takahiro Tsuji et al.	5
8	MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expression	Cell Death and Disease	Yuto Yasuda, Hiroaki Ozasa et al.	32
9	YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation	Nature Communications	Takahiro Tsuji, Hiroaki Ozasa et al.	57
10	PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade	European Journal of Cancer	Hironori Yoshida, Takashi Nomizo et al.	13
11	Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab	Scientific Reports	Tomoko Funazo, Takashi Nomizo et al.	13
12	Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model	Molecular Cancer Research	Takahiro Tsuji, Hiroaki Ozasa et al.	41
13	Efficacy of Ceritinib After Alectinib for ALK-positive Non-small Cell Lung Cancer	In Vivo	Hironori Yoshida, Young Hak Kim et al.	7
14	Retrospective analysis of acute exacerbation of interstitial lung diseases with nanoparticle albumin-bound paclitaxel in patients with advanced lung cancer with preexisting interstitial lung disease	Molecular and Clinical Oncology	Yuto Yasuda, Takashi Nomizo et al.	9
15	Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients	Scientific Reports	Takashi Nomizo, Hiroaki Ozasa et al.	69
16	EGFR T790M Detection in Circulating Tumor DNA from Non-small Cell Lung Cancer Patients Using the PNA-LNA Clamp Method	Anticancer Research	Hironori Yoshida, Young Hak Kim et al.	10
17	Nivolumab in non-small-cell lung cancer with EGFR mutation	Annals of Oncology	Hironori Yoshida, Hiroaki Ozasa et al.	29
18	Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small cell lung cancer	Annals of Oncology	Hiroaki Ozasa, Susumu Satô et al.	2
19	Nontuberculous mycobacterial infection in chronic obstructive pulmonary disease		Satoshi Okamori, Eisaku Tanaka et al.	1
20	[Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up].	PubMed	Hikaru Matsumoto, Hironori Ishida et al.	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact